Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Details 1) - USD ($)	May 31, 2023	Aug. 31, 2022
Net Balance	$ 276,898	$ 315,505
Canada [Member]
Net Balance	152,415	215,474
Cost	555,073	548,256
Addition	0	6,817
US [Member]
Net Balance	124,483	100,031
Cost	140,487	98,050
Addition	33,748	42,375
Leasehold Improvements [Member]
Net Balance	24,768	65,296
Leasehold Improvements [Member] \| Canada [Member]
Net Balance	24,768	65,296
Cost	259,981	259,981
Addition	0	0
Leasehold Improvements [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Furniture Fixtures Equipment [Member]
Net Balance	3,474	8,288
Furniture Fixtures Equipment [Member] \| Canada [Member]
Net Balance	3,474	8,288
Cost	31,126	31,126
Addition	0	0
Furniture Fixtures Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	0	0
Lab Equipment [Member]
Net Balance	242,848	232,564
Lab Equipment [Member] \| Canada [Member]
Net Balance	118,365	132,533
Cost	193,185	193,185
Addition	0	0
Lab Equipment [Member] \| US [Member]
Net Balance	124,483	100,031
Cost	140,487	98,050
Addition	33,748	42,375
Computer Equipment [Member]
Net Balance	5,808	9,357
Computer Equipment [Member] \| Canada [Member]
Net Balance	5,808	9,357
Cost	70,781	63,964
Addition	0	6,817
Computer Equipment [Member] \| US [Member]
Net Balance	0	0
Cost	0	0
Addition	$ 0	$ 0